Filing Details

Accession Number:
0001140361-24-032761
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-09 16:05:18
Reporting Period:
2024-07-08
Accepted Time:
2024-07-09 16:05:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1281895 Rocket Pharmaceuticals Inc. RCKT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1973240 Andrew Mark White C/O Rocket Pharmaceuticals, Inc.
9 Cedarbrook Drive
Cranbury NJ 08512
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-08 3,026 $20.40 72,220 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. RSUs vest one-third (1/3) upon the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments over the following two years.